05.08.2015 • News

Germany’s Merck to Mentor Scheme Start-ups

German pharmaceuticals and chemicals group Merck KGaA has launched a program to encourage international start-ups in its business fields of healthcare, life sciences and performance materials to apply for funding of innovative ideas.

The Accelerator scheme, which runs for three months – applications can be submitted until Aug. 14 via the initiative’s website – is aimed at young companies in the three Merck fields as well as IT.

Three selected start-ups will receive strategic and operational advice in addition to financial support of €25,000 offered in the form of a silent participation.

Merck said the program does not foresee an equity investment, nor does it influence the start-up’s operational and strategic management. The first selected will be invited to move into the company’s newly built modular innovation center in Darmstadt from Sept. 14.

Along with providing financial and infrastructure assistance, Merck plans to coach the start-ups, provide mentors for their development and enable them to participate in several training sessions. At the end of the three-month period, the companies will become part of the company’s start-up network.

“Building an alumni network is one of the three long-term goals,” said Michael Gamber, head of Merck’s Innovation Center. The company wants to provide a home for start-ups and continue collaborating with them, he said.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.